A Drosophila ortholog of the human MRJ modulates polyglutamine toxicity and aggregation

Zahra Fayazi1, Srimoyee Ghosh, Susan Marion

  • 1Department of Physiology and Biophysics, Center for Neuroscience, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, USA.

Neurobiology of Disease
|August 29, 2006
PubMed

Insights

Researchers found that dMRJ and dHDJ1 proteins can suppress polyglutamine (polyQ) toxicity in Drosophila. While both increase soluble polyQ proteins, dHDJ1 promotes aggregation, unlike dMRJ.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Expanded polyglutamine (polyQ) tracts in proteins cause cytotoxicity and inclusions in Drosophila.
  • A P-element insertion upstream of the dmrj gene suppressed polyQ-induced eye pigmentation loss.

Purpose of the Study:

  • To investigate the role of dmrj, an ortholog of human MRJ, in suppressing polyQ toxicity.
  • To compare the functions of dMRJ and dHDJ1, both J domain proteins, in polyQ toxicity.

Main Methods:

  • Quantitative polymerase chain reaction (qPCR) to confirm dmrj overexpression.
  • Transgenic expression of dMRJ and dHDJ1 in Drosophila.
  • Observation of polyQ toxicity markers (eye pigmentation, structural integrity) and protein aggregation.

Main Results:

  • Transgenic dMRJ suppressed polyQ toxicity and colocalized with inclusions in neurons.
  • dHDJ1, but not dMRJ, promoted cytoplasmic aggregation when expressed before polyQ proteins.
  • Both dMRJ and dHDJ1 increased detergent-soluble, monomeric polyQ-expanded proteins.

Conclusions:

  • dMRJ and dHDJ1 exhibit functional similarities and differences in suppressing polyQ toxicity.
  • J domain proteins play a complex role in modulating polyQ protein aggregation and toxicity.